Results 321 to 330 of about 1,101,764 (406)

Atherosclerotic Plaque Progression and Incident Cardiovascular Events in a 10‐Year Prospective Study of Patients With Systemic Lupus Erythematosus: The Impact of Persistent Cardiovascular Risk Factor Target Attainment and Sustained DORIS Remission

Arthritis &Rheumatology, EarlyView.
Objective Cardiovascular disease (CVD) is a leading cause of death in individuals with systemic lupus erythematosus (SLE). We assessed atherosclerotic plaque progression and incident cardiovascular events in patients with SLE over a 10‐year follow‐up.
Nikolaos Papazoglou, Petros P. Sfikakis, Maria G. Tektonidou   +2 more
wiley   +1 more source

Impact of Biological Therapies on Quality of Life in Rheumatoid Arthritis: A Narrative Review. [PDF]

Open Access Rheumatol
Mamasaidov A, Sakibaev K, Zhumabaeva S, Isakov U, Eshbaeva CA, Abdyllaev J, Abdikhalilov B, Salieva RS.   +7 more
europepmc   +1 more source

Nursing Care of Patients with Rheumatoid Arthritis During Zherapy with Cortisone

, 1953
By Julie E. Miale, Charles M. Plotz
openalex   +1 more source

An Immunosenescent CD8+ T Cell Subset in Patients with Axial Spondyloarthritis and Psoriatic Arthritis Links Spontaneous Motility to Telomere Shortening and Dysfunction

Arthritis &Rheumatology, EarlyView.
Objective A pathogenetic role of CD8+ T lymphocytes in radiographic axial spondyloarthritis (r‐axSpA) and other spondyloarthritis (SpA) is sustained by genome‐wide association studies and by the expansion of public T cell clonotypes in the target tissues.
Giorgia Paldino, Valentina Tedeschi, Valentina Proganò, Erica Salvati, Valerio Licursi, Eleonora Vertecchi, Alexandru L. Bivolaru, Emanuele Molteni, Rossana Scrivo, Mattia Congia, Alberto Cauli, Rosalba Caccavale, Marino Paroli, Martina Kunkl, Loretta Tuosto, Rosa Sorrentino, Maria Teresa Fiorillo   +16 more
wiley   +1 more source

IRAK3 is upregulated in rheumatoid arthritis synovium and delays the onset of experimental arthritis. [PDF]

Front Immunol
Borghese F, Williams RO, Clanchy FIL.
europepmc   +1 more source

Some Anti-rheumatic Agents in Rheumatoid Arthritis

, 1953
Mizuho A. Kido, Minoru Matsubara, M. Ôta   +2 more
openalex   +2 more sources

Proteomic Profiling of the Large‐Vessel Vasculitis Spectrum Identifying Shared Signatures of Innate Immune Activation and Stromal Remodeling

Arthritis &Rheumatology, EarlyView.
Objective Takayasu arteritis (TAK) and giant cell arteritis (GCA), the most common forms of large‐vessel vasculitis (LVV), can result in serious morbidity. Understanding the molecular basis of LVV should aid in developing better biomarkers and treatments. Methods Plasma proteomic profiling of 184 proteins was performed in two cohorts. Cohort 1 included
Robert T. Maughan, Erin Macdonald‐Dunlop, Lubna Haroon‐Rashid, Louise Sorensen, Natalie Chaddock, Shauna Masters, Andrew Porter, Marta Peverelli, Charis Pericleous, Andrew Hutchings, James Robinson, Taryn Youngstein, Raashid A. Luqmani, Justin C. Mason, Ann W. Morgan, James E. Peters   +15 more
wiley   +1 more source

Five-year follow-up of patients with difficult-to-treat rheumatoid arthritis. [PDF]

Rheumatology (Oxford)
Takanashi S, Takeuchi T, Kaneko Y.
europepmc   +1 more source

Diagnostic Criteria for Rheumatoid Arthritis: 1958 Revision

, 1959

openalex   +1 more source

Genetic data do not provide evidence that lower sclerostin is associated with increased risk of atherosclerosis: comment on the article by Zheng et al

Arthritis &Rheumatology, EarlyView.
James R. Staley, Olga Giannakopoulou, Gill Holdsworth, Martin Armstrong   +3 more
wiley   +1 more source